Published online Jul 5, 2022. doi: 10.4292/wjgpt.v13.i4.33
Peer-review started: January 15, 2022
First decision: March 8, 2022
Revised: March 10, 2022
Accepted: June 13, 2022
Article in press: June 13, 2022
Published online: July 5, 2022
Processing time: 166 Days and 16.2 Hours
Biliary atresia (BA) and choledochal cysts are diseases of the intrahepatic and extrahepatic biliary tree. While their exact etiopathogeneses are not known, they should be treated promptly due to the potential for irreversible parenchymal liver disease. A diagnosis of BA may be easy or complicated, but should not be delayed. BA is always treated surgically, and performing the surgery before the age of 2 mo greatly increases its effectiveness and extends the time until the need for liver transplantation arises. While the more common types of choledochal cysts require surgical treatment, some can be treated with endoscopic retrograde cholangiopancreatography. Choledochal cysts may cause recurrent cholangitis and the potential for malignancy should not be ignored.
Core Tip: Biliary atresia (BA) and choledochal cysts are diseases that cause obstructive cholestasis. While the diagnosis of BA can be rather complicated, it should be made as early as possible and treated with a Kasai hepatoportoenterostomy before the age of 2 mo for a good prognosis. All patients with persistent acholic stool and elevated gamma-glutamyl transferase should be evaluated for BA, although normal ultrasonography will not rule out BA, and such patients are candidates for intraoperative cholangiography. Choledochal cysts can present symptoms at any age, and as recurrent cholangitis attacks will lead to chronic liver disease with potential malignancy, treatment and long-term follow-up are essential.